Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | PLAU | P00749 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | CCNC | P24863 | 1/20 | 0.42 |
| ▸ | CDK8 | P49336 | 1/20 | 0.42 |
| ▸ | PLK1 | P53350 | 6/20 | 0.42 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | MMP13 | P45452 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28498281 | 0.80 | PLK1 (0.45) | SMN1; SMN2THRBHDAC8HDAC6HDAC2 | |
| SCHEMBL10031355 | 0.79 | LIMK1 (0.47) | HPGDCA2 | |
| SCHEMBL10846058 | 0.78 | MAPT (0.46) | SMN1; SMN2THRBHDAC8HDAC6HPGD | |
| SCHEMBL2486863 | 0.77 | KDM4E (0.46) | SMN1; SMN2THRBHPGDTSHRCA2 | |
| SCHEMBL15024214 | 0.72 | MAPT (0.51) | SMN1; SMN2HPGDTSHRCA2 | |
| SCHEMBL19929598 | 0.71 | SMN1; SMN2 (0.60) | SMN1; SMN2THRBCCNCCDK8PLK1 | |
| SCHEMBL8566294 | 0.71 | RAB9A (0.68) | SMN1; SMN2HPGDHTT | |
| SCHEMBL250247 | 0.71 | HDAC6 (0.80) | SMN1; SMN2HDAC8HDAC6HDAC2PLAU | |
| SCHEMBL13709608 | 0.70 | PLAU (0.61) | SMN1; SMN2THRBHDAC8HDAC6HDAC2 | |
| SCHEMBL1748004 | 0.70 | SMN1; SMN2 (0.63) | SMN1; SMN2THRBPLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180122585-A1 | PHOTOELECTRIC CONVERSION ELEMENT, AND SOLAR CELL USING THE SAME | FUJIFILM CORPORATION (JP) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180122585-A1 | PHOTOELECTRIC CONVERSION ELEMENT, AND SOLAR CELL USING THE SAME | SUN2, SLC9A2, SLC43A3 | SMN1; SMN2 4582/4885THRB 4698/4885HDAC8 2982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.